• Overview
  • Eligibility
  • More info
  • Locations

A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris (NCT02758041)

This study is proposed to evaluate Sebacia Microparticle treatment in patients with facial inflammatory acne vulgaris.
  • Device: Sebacia Microparticles
    Ages eligible for Study
    16 Years to 45 Years
    Genders eligible for Study
    All
    Accepts Healthy Volunteers
    No
    Inclusion Criteria:
    • Male or female, 16-45 years of age.
    • Moderate to moderately-severe facial inflammatory acne vulgaris
    • Fitzpatrick skin phototype I-III
    Exclusion Criteria:
    • Pregnant, lactating, nursing or planning to become pregnant
    • Tattoo in the treatment area
    • Active skin disease, excessive scarring or excess facial hair in the treatment area
    • Certain current or recent acne treatments
    • Recent light treatments including Intense Pulsed Light or other lasers, microdermabrasion or chemical peels in the treatment area
    • Contraindicated for laser treatment, or is unable or unwilling to avoid excessive sun exposure or tanning bed use
    • Known allergy to gold

    3 locations

    Status:
    completed
    Type:
    Interventional
    Phase:
    -
    Start:
    31 January, 2016
    Updated:
    04 September, 2017
    Participants:
    85
    A girl giving information about available additional trials.

    FindMeCure helps you find, understand and join clinical trials from all over the world.

    There are more clinical trials for your condition!